Top of this page
Skip navigation, go straight to the content

Clinical Studies Clinical studies index EVENITY (Romosozumab)

EVENITY® (Romosozumab)

Disease area
studied
Abbreviated title Phase Study ID Registry database Study results Plain language summary Publication (if available)
Osteoporosis
A study to learn how romosozumab worked in men with osteoporosis
Phase 3 20110174
Completed
LINK
Lewiecki et al., Journal of clinical endocrinology and metabolism 2018; 103(9):3183–93
Osteoporosis A study to learn how romosozumab worked in women with osteoporosis who had gone through menopause Phase 3 20110142
Completed
LINK
Brown, J Bone Miner Res 2021 epub Cosman, J Bone Miner Res 2020; 35(7):1333–42
Osteoporosis A study to learn how romosozumab worked in women with osteoporosis who had gone through menopause Phase 3 20070337
Completed

LINK

Cosman, N Engl J Med 2016; 375(16):1532–43
Cosman, Journal of bone and mineral research 2018; 33(7):1219–26
Cosman, J Bone Miner Res 2018; 33(8):1407–16
Lewiecki EM, J Bone Miner Res 2019; 34(3):419–28
McCloskey, Osteoporos Int 2021; 32(8):1601-1608
Miyauchi, Arch Osteoporos 2019; 14(1):59
Chavassieux, Journal of bone and mineral research 2019; 34(9):1597–608
Miyauchi Journal of bone and mineral metabolism 2021; 39(2):278–88
Osteoporosis postmenopausal
European non-interventional post-authorization safety study related to serious cardiovascular events of myocardial infarction and stroke, and all-cause mortality for romosozumab by the EU-ADR Alliance
N/A OP0004
Ongoing
EUPAS35881
Osteoporosis postmenopausal European non-interventional post-authorization safety study related to adherence to the risk minimization measures for romosozumab by the EU-ADR Alliance
N/A OP0005
Ongoing
EUPAS35956
Osteoporosis postmenopausal European non-interventional post-authorization safety study related to serious infections for romosozumab by the EU-ADR Alliance
N/A OP0006
Ongoing
EUPAS36005